Enhancement of COPD biological networks using a web-based collaboration interface

F1000Research

Volumn 4, Issue , 2015, Pages

  Hoeng, Julia ^a   Boue, Stephanie ^a   Fields, Brett ^b   Park, Jennifer ^b   Peitsch, Manuel C ^a   Schlage, Walter K ^a   Talikka, Marja ^a   Binenbaum, Ilona ^c   Bondarenko, Vladimir ^d   Bulgakov, Oleg V ^e   Cherkasova, Vera ⁱ   Diaz Diaz, Norberto ^f   Fedorova, Larisa ^g   Guryanova, Svetlana ^h   Guzova, Julia ^k   Igorevna Koroleva, Galina ^j   Kozhemyakina, Elena ^k   Kumar, Rahul ^l   Lavid, Noa ^m   Lu, Qingxian ⁿ   Menon, Swapna ^o   Ouliel, Yael ^m   Peterson, Samantha C ^p   Prokhorov, Alexander ^h   Sanders, Edward ^q   Schrier, Sarah ^r   Schwaitzer Neta, Golan ^m   Shvydchenko, Irina ^s   Tallam, Aravind ^t   Villa Fombuena, Gema ^f   Wu, John ^u   Yudkevich, Ilya ^v   Zelikman, Mariya ^w   more..

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Selventa   (United States)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^d TOURO UNIVERSITY NEVADA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^g UNIVERSITY OF TOLEDO   (United States)

^h SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

ⁱ Private ^*  (United States)

^j UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^k Private Practice   (United States)

^l INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

^m TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

ⁿ UNIVERSITY OF LOUISVILLE   (United States)

^o AnalyzeDat Consulting Services   (India)

^p NORTHEASTERN UNIVERSITY   (United States)

^q Edward Sanders Scientific Consulting   (Switzerland)

^r MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^s Kuban State University of Physical Culture Sport and Tourism   (Russian Federation)

^t UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^u Cal Biopharma   (United States)

^v UNIVERSITY OF MANCHESTER   (United Kingdom)

^w UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER INTERFACE; COMPUTER NETWORK; HELPER CELL; HUMAN; MACROPHAGE; MACROPHAGE SIGNALING; NEUTROPHIL; NEUTROPHIL SIGNALING; SIGNAL TRANSDUCTION; TH1 TH2 SIGNALING; TRANSCRIPTOMICS; WEB BROWSER;

EID: 84924942498     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.5984.1     Document Type: Article

References (65)

1. Kanehisa M Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27-30. 10592173 10.1093/nar/28.1.27 102409
2. Kanehisa M Goto S Sato Y: Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42(Database issue):D199-205. 24214961 10.1093/nar/gkt1076 3965122
3. Gebel S Lichtner RB Frushour B: Construction of a computable network model for DNA damage, autophagy, cell death, and senescence. Bioinform Biol Insights. 2013;7:97-117. 23515068 10.4137/BBI.S11154 3596057
4. Schlage WK Westra JW Gebel S: A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Syst Biol. 2011;5:168. 22011616 10.1186/1752-0509-5-168 3224482
5. Westra JW Schlage WK Frushour BP: Construction of a computable cell proliferation network focused on non-diseased lung cells. BMC Syst Biol. 2011;5:105. 21722388 10.1186/1752-0509-5-105 3160372
6. Westra JW Schlage WK Hengstermann A: A modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue. Bioinform Biol Insights. 2013;7:167-192. 23843693 10.4137/BBI.S11509 3700945
7. Park JS Schlage WK Frushour BP: Construction of a Computable Network Model of Tissue Repair and Angiogenesis in the Lung. J Clinic Toxicol. 2013;S12:002. 10.4172/2161-0495.S12-002
8. Catlett NL Bargnesi AJ Ungerer S: Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data. BMC Bioinformatics. 2013;14:340. 24266983 10.1186/1471-2105-14-340 4222496
9. Lopez AD Murray CC: The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-1243. 9809543 10.1038/3218
10. Ojo O Lagan AL Rajendran V: Pathological changes in the COPD lung mesenchyme - Novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther. 2014;29(2):121-8. 24747433 10.1016/j.pupt.2014.04.004
11. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD).2014. Reference Source
12. Chapman RS He X Blair AE: Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ. 2005;331(7524):1050. 16234255 10.1136/bmj.38628.676088.55 1283181
13. Ekici A Ekici M Kurtipek E: Obstructive airway diseases in women exposed to biomass smoke. Environ Res. 2005;99(1):93-98. 16053933 10.1016/j.envres.2005.01.004
14. Hnizdo E Sullivan PA Bang KM: Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data. Am J Ind Med. 2004;46(2):126-135. 15273964 10.1002/ajim.20042
15. Winchester JW: Regional anomalies in chronic obstructive pulmonary disease; comparison with acid air pollution particulate characteristics. Arch Environ Contam Toxicol. 1989;18(1-2):291-306. 2923495 10.1007/BF01056216
16. Fischer BM Pavlisko E Voynow JA: Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011;6:413-421. 21857781 10.2147/COPD.S10770 3157944
17. Calverley PM Walker P: Chronic obstructive pulmonary disease. Lancet. 2003;362(9389):1053-1061. 14522537 10.1016/S0140-6736(03)14416-9
18. Adcock IM Caramori G Barnes PJ: Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration; international review of thoracic diseases. 2011;81(4):265-284. 21430413 10.1159/000324601
19. Barnes PJ: Chronic obstructive pulmonary disease *12: New treatments for COPD. Thorax. 2003;58(9):803-808. 12947145 10.1136/thorax.58.9.803 1746809
20. Ansari S Binder J Boue S: On Crowd-verification of Biological Networks. Bioinform Biol Insights. 2013;7:307-325. 24151423 10.4137/BBI.S12932 3798292
21. Turan N Kalko S Stincone A: A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol. 2011;7(9):e1002129. 21909251 10.1371/journal.pcbi.1002129 3164707
22. Kaneko Y Yatagai Y Yamada H: The search for common pathways underlying asthma and COPD. Int J Chron Obstruct Pulmon Dis. 2013;8:65-78. 23378757 10.2147/COPD.S39617 3558318
23. Maier D Kalus W Wolff M: Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol. 2011;5:38. 21375767 10.1186/1752-0509-5-38 3060864
24. Cohen HY Lavu S Bitterman KJ: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 2004;13(5):627-638. 15023334 10.1016/S1097-2765(04)00094-2
25. Cohen HY Miller C Bitterman KJ: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390-392. 15205477 10.1126/science.1099196
26. Luo C Li Y Yang L: A cigarette component acrolein induces accelerated senescence in human diploid fibroblast IMR-90 cells. Biogerontology. 2013;14(5):503-511. 24026667 10.1007/s10522-013-9454-3
27. Motta MC Divecha N Lemieux M: Mammalian SIRT1 represses forkhead transcription factors. Cell. 2004;116(4):551-563. 14980222 10.1016/S0092-8674(04)00126-6
28. Yao H Chung S Hwang JW: SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest. 2012;122(6):2032-2045. 22546858 10.1172/JCI60132 3366403
29. Mortaz E Kraneveld AD Smit JJ: Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS One. 2009;4(3):e4946. 19293939 10.1371/journal.pone.0004946 2655711
30. Freeman CM Curtis JL Chensue SW: CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol. 2007;171(3):767-776. 17640964 10.2353/ajpath.2007.061177 1959492
31. Safford M Collins S Lutz MA: Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol. 2005;6(5):472-480. 15834410 10.1038/ni1193
32. Elser B Lohoff M Kock S: IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity. 2002;17(6):703-712. 12479817 10.1016/S1074-7613(02)00471-5
33. Han ST Mosher DF: IL-5 induces suspended eosinophils to undergo unique global reorganization associated with priming. Am J Respir Cell Mol Biol. 2014;50(3):654-664. 24156300 10.1165/rcmb.2013-0181OC 4068932
34. Gemelli C Zanocco Marani T Bicciato S: MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation. Biochim Biophys Acta. 2014;1843(5):955-964. 24472656 10.1016/j.bbamcr.2014.01.021
35. Ma B Kang MJ Lee CG: Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema. J Clin Invest. 2005;115(12):3460-3472. 16284650 10.1172/JCI24858 1280966
36. Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S29-32. 10556166 10.1164/ajrccm.160.supplement_1.9
37. Wang X Bu HF Zhong W: MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosis. Mol Med. 2013;19:170-182. 23552724 10.2119/molmed.2012.00260 3745596
38. Brusselle GG Joos GF Bracke KR: New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015-1026. 21907865 10.1016/S0140-6736(11)60988-4
39. Korns D Frasch SC Fernandez-Boyanapalli R: Modulation of macrophage efferocytosis in inflammation. Front Immunol. 2011;2:57. 22566847 10.3389/fimmu.2011.00057 3342042
40. Cosio MG Saetta M Agusti A: Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(23):2445-2454. 19494220 10.1056/NEJMra0804752
41. Hodge S Hodge G Ahern J: Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007;37(6):748-755. 17630319 10.1165/rcmb.2007-0025OC
42. Richens TR Linderman DJ Horstmann SA: Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. Am J Respir Crit Care Med. 2009;179(11):1011-1021. 19264974 10.1164/rccm.200807-1148OC 2689911
43. Ishikawa N Hattori N Tanaka S: Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis. Respiration; international review of thoracic diseases. 2011;82(1):10-18. 21474912 10.1159/000324539
44. Herold S Mayer K Lohmeyer J: Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol. 2011;2:65. 22566854 10.3389/fimmu.2011.00065 3342347
45. Funk CD: Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871-1875. 11729303 10.1126/science.294.5548.1871
46. Chiang N Serhan CN Dahlen SE: The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev. 2006;58(3):463-487. 16968948 10.1124/pr.58.3.4
47. Godson C Mitchell S Harvey K: Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol. 2000;164(4):1663-1667. 10657608 10.4049/jimmunol.164.4.1663
48. Arita M Ohira T Sun YP: Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol. 2007;178(6):3912-3917. 17339491 10.4049/jimmunol.178.6.3912
49. Schwab JM Chiang N Arita M: Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447(7146):869-874. 17568749 10.1038/nature05877 2757086
50. Rose JJ Foley JF Yi L: Cholesterol is obligatory for polarization and chemotaxis but not for endocytosis and associated signaling from chemoattractant receptors in human neutrophils. J Biomed Sci. 2008;15(4):441-461. 18311596 10.1007/s11373-008-9239-x
51. Kumar S Xu J Perkins C: Cdc42 regulates neutrophil migration via crosstalk between WASp, CD11b, and microtubules. Blood. 2012;120(17):3563-3574. 22932798 10.1182/blood-2012-04-426981 3482864
52. Schmid E Warner RL Crouch LD: Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Inflammation. 1997;21(3):325-333. 9246574 10.1023/A:1027302017117
53. Ottonello L Montecucco F Bertolotto M: CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell Signal. 2005;17(3):355-363. 15567066 10.1016/j.cellsig.2004.08.002
54. Prill RJ Saez-Rodriguez J Alexopoulos LG: Crowdsourcing network inference: the DREAM predictive signaling network challenge. Sci Signal. 2011;4(189):mr7. 21900204 10.1126/scisignal.2002212 3465072
55. Meyer P Alexopoulos LG Bonk T: Verification of systems biology research in the age of collaborative competition. Nat Biotechnol. 2011;29(9):811-815. 21904331 10.1038/nbt.1968
56. Meyer P Hoeng J Rice JJ: Industrial methodology for process verification in research (IMPROVER): toward systems biology verification. Bioinformatics. 2012;28(9):1193-1201. 22423044 10.1093/bioinformatics/bts116 3338013
57. Tarca AL Lauria M Unger M: Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics. 2013;29(22):2892-2899. 23966112 10.1093/bioinformatics/btt492 3810846
58. [https://bionet.sbvimprover.com/].
59. Ezzie ME Crawford M Cho JH: Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 2012;67(2):122-131. 21940491 10.1136/thoraxjnl-2011-200089
60. Gemelli C Orlandi C Zanocco Marani T: The vitamin D3/Hox-A10 pathway supports MafB function during the monocyte differentiation of human CD34+ hemopoietic progenitors. J Immunol. 2008;181(8):5660-5672. 18832725 10.4049/jimmunol.181.8.5660
61. Ammous Z Hackett NR Butler MW: Variability in small airway epithelial gene expression among normal smokers. Chest. 2008;133(6):1344-1353. 18339782 10.1378/chest.07-2245 3632367
62. Shaykhiev R Otaki F Bonsu P: Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2011;68(5):877-892. 20820852 10.1007/s00018-010-0500-x 3838912
63. Shaykhiev R Krause A Salit J: Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol. 2009;183(4):2867-2883. 19635926 10.4049/jimmunol.0900473 2873685
64. [http://www.openbel.org/].
65. Boue S Fields B Hoeng J: Original networks, NVC networks and COPD data sets used in: Enhancement of COPD biological networks using a web-based collaboration interface. Figshare. 2014. Data Source